Search for Clinical Trial Results
Lupus Erythematosus, Systemic - 30 Studies Found
Status | Study |
Active, not recruiting |
Study Name: A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic Date: 2015-07-17 Interventions:
|
Enrolling by invitation |
Study Name: An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults Condition: Lupus Erythematosus, Systemic Date: 2012-12-17 Interventions: Biological: MEDI-546 MEDI-546, IV q4wks for 104 weeks |
Suspended |
Study Name: Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine Condition: Systemic Lupus Erythematosus Date: 2008-10-17 Interventions:
|
Active, not recruiting |
Study Name: Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients Condition: Systemic Lupus Erythematosus Date: 2014-11-18 Interventions:
|
RECRUITING |
Study Name: Efficacy and Safety of Telitacicept in Early SLE Condition: Date: 2024-05-19 Interventions: 160mg once a week for 48 weeks |
RECRUITING |
Study Name: Engagement in CHildhood-Onset Systemic Lupus Condition: Lupus Erythematosus, Systemic Date: 2024-05-19 Interventions: Valera mobile health application will provide educational materials around mental health and Systemic Lupus Erythematosus (SLE) and the ability to con |
RECRUITING |
Study Name: Relationship Between Data Obtained With the LuGENE� Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE) Condition: Lupus Erythematosus, Systemic Date: 2024-05-19 Interventions: LuGENE�, a transcriptomic-based LDT, with standard evaluation of patients diagnosed with SLE |
RECRUITING |
Study Name: A Study of CC-97540 in Participants With Severe, Refractory Systemic Lupus Erythematosus (SLE) Condition: Lupus Erythematosus, Systemic Date: 2024-05-19 Interventions: Specified dose on specified days |
RECRUITING |
Study Name: A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms. Condition: Lupus Erythematosus, Systemic Date: 2024-05-19 Interventions: Placebo (intravenous infusion) |
RECRUITING |
Study Name: A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic Date: 2024-05-19 Interventions: Cenerimod will be supplied as film-coated tablets at the dose of 4 mg. |